Wafra Investment Advisory Group Inc. NY trimmed its stake in UnitedHealth Group (NYSE:UNH) by 25.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 44,592 shares of the healthcare conglomerate’s stock after selling 15,450 shares during the period. Wafra Investment Advisory Group Inc. NY’s holdings in UnitedHealth Group were worth $9,831,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of UNH. Exane Derivatives raised its holdings in shares of UnitedHealth Group by 15,333.3% in the fourth quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after buying an additional 460 shares during the period. Aevitas Wealth Management Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $102,000. Pathstone Family Office LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $129,000. Trustcore Financial Services LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $133,000. Finally, Intellectus Partners LLC raised its holdings in shares of UnitedHealth Group by 18.2% in the second quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock worth $152,000 after buying an additional 126 shares during the period. 86.78% of the stock is owned by institutional investors and hedge funds.
Shares of NYSE:UNH opened at $235.06 on Friday. UnitedHealth Group has a 12-month low of $166.65 and a 12-month high of $250.79. The firm has a market capitalization of $228,136.20, a PE ratio of 23.34, a P/E/G ratio of 1.36 and a beta of 0.77. The company has a current ratio of 0.71, a quick ratio of 0.73 and a debt-to-equity ratio of 0.56.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.91 by $0.13. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The business had revenue of $55.19 billion for the quarter, compared to the consensus estimate of $54.90 billion. During the same period last year, the business posted $2.37 EPS. The business’s revenue was up 13.3% compared to the same quarter last year. equities research analysts forecast that UnitedHealth Group will post 12.61 EPS for the current year.
UNH has been the topic of several recent analyst reports. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 price target on the stock in a report on Tuesday, April 3rd. Deutsche Bank increased their price target on UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Cantor Fitzgerald reiterated a “buy” rating and issued a $235.00 price target on shares of UnitedHealth Group in a report on Tuesday, January 16th. BMO Capital Markets increased their price target on UnitedHealth Group from $14.50 to $275.00 and gave the stock an “outperform” rating in a report on Wednesday, January 17th. Finally, Royal Bank of Canada reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday. Three analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $251.13.
In other news, Director William C. Ballard, Jr. sold 10,000 shares of UnitedHealth Group stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total value of $2,463,800.00. Following the transaction, the director now directly owns 76,637 shares in the company, valued at approximately $18,881,824.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Steven H. Nelson sold 14,233 shares of UnitedHealth Group stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $230.22, for a total value of $3,276,721.26. Following the completion of the transaction, the chief executive officer now owns 18,219 shares in the company, valued at $4,194,378.18. The disclosure for this sale can be found here. Insiders sold a total of 77,019 shares of company stock worth $17,879,133 over the last quarter. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.